Latest Insider Transactions at Poseida Therapeutics, Inc. (PSTX)
This section provides a real-time view of insider transactions for Poseida Therapeutics, Inc. (PSTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Poseida Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Poseida Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Eric Ostertag Director |
SELL
Bona fide gift
|
Direct |
93,955
-13.47%
|
-
|
|
Dec 21
2021
|
Johanna Mylet Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,716
+8.03%
|
$5,716
$1.55 P/Share
|
|
Dec 06
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+13.99%
|
$10,000
$1.32 P/Share
|
|
Dec 06
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,828
+0.02%
|
$10,968
$6.9 P/Share
|
|
Dec 02
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
4,296
+0.04%
|
$25,776
$6.88 P/Share
|
|
Dec 01
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
18,365
+0.19%
|
$110,190
$6.85 P/Share
|
|
Nov 30
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
28,592
+0.3%
|
$171,552
$6.85 P/Share
|
|
Nov 29
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
11,057
+0.11%
|
$66,342
$6.89 P/Share
|
|
Nov 26
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
27,251
+0.28%
|
$163,506
$6.81 P/Share
|
|
Nov 24
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,054
+0.01%
|
$6,324
$6.89 P/Share
|
|
Nov 23
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
14,625
+0.15%
|
$87,750
$6.77 P/Share
|
|
Nov 19
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
11,104
+0.12%
|
$77,728
$7.44 P/Share
|
|
Nov 19
2021
|
Eric Ostertag Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.14%
|
$9,000
$9.15 P/Share
|
|
Nov 18
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
71,312
+0.74%
|
$499,184
$7.18 P/Share
|
|
Nov 17
2021
|
Kerry D. Ingalls Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$14,000
$7.0 P/Share
|
|
Nov 17
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
280,384
+2.87%
|
$1,962,688
$7.21 P/Share
|
|
Nov 16
2021
|
Malin Life Sciences Holdings LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
27,680
+0.3%
|
$193,760
$7.17 P/Share
|
|
Nov 08
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
18,924
-0.27%
|
$132,468
$7.09 P/Share
|
|
Oct 11
2021
|
Eric Ostertag Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,525
+2.59%
|
$166,725
$9.15 P/Share
|
|
Oct 01
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
20,029
-0.28%
|
$140,203
$7.02 P/Share
|
|
Sep 20
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
20,000
-11.07%
|
$160,000
$8.0 P/Share
|
|
Sep 14
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
20,000
-9.97%
|
$160,000
$8.14 P/Share
|
|
Sep 13
2021
|
Eric Ostertag Director |
BUY
Exercise of conversion of derivative security
|
Direct |
21,281
+1.54%
|
$106,405
$5.16 P/Share
|
|
Sep 09
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.26%
|
$10,000
$1.32 P/Share
|
|
Sep 02
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
61,262
-0.86%
|
$490,096
$8.34 P/Share
|
|
Sep 01
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
51,149
-0.71%
|
$409,192
$8.46 P/Share
|
|
Aug 20
2021
|
Matthew A. Spear Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-8.79%
|
$32,000
$8.79 P/Share
|
|
Aug 20
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+8.08%
|
$4,000
$1.32 P/Share
|
|
Aug 06
2021
|
Eric Ostertag Director |
BUY
Exercise of conversion of derivative security
|
Direct |
111,149
+14.52%
|
$1,000,341
$9.15 P/Share
|
|
Aug 03
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
19,936
-0.28%
|
$139,552
$7.99 P/Share
|
|
Aug 02
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
13,737
-0.19%
|
$109,896
$8.13 P/Share
|
|
Jul 28
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+32.53%
|
$20,000
$1.32 P/Share
|
|
Jul 02
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
27,542
-0.19%
|
$247,878
$9.28 P/Share
|
|
Jul 01
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
20,563
-0.28%
|
$185,067
$9.77 P/Share
|
|
Jun 17
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+18.88%
|
$5,000
$1.32 P/Share
|
|
Jun 11
2021
|
Matthew A. Spear Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-19.53%
|
$36,000
$9.44 P/Share
|
|
Jun 11
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+16.34%
|
$4,000
$1.32 P/Share
|
|
Jun 02
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
40,722
-0.56%
|
$325,776
$8.34 P/Share
|
|
Jun 01
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
41,194
-0.56%
|
$329,552
$8.61 P/Share
|
|
May 04
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
35,986
-0.49%
|
$287,888
$8.44 P/Share
|
|
May 03
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
18,326
-0.25%
|
$164,934
$9.01 P/Share
|
|
Apr 23
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+23.27%
|
$5,000
$1.32 P/Share
|
|
Apr 21
2021
|
Matthew A. Spear Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-25.83%
|
$32,000
$8.44 P/Share
|
|
Apr 21
2021
|
Matthew A. Spear Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+20.53%
|
$4,000
$1.32 P/Share
|
|
Apr 05
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
57,819
-0.39%
|
$520,371
$9.97 P/Share
|
|
Apr 01
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
57,181
-0.76%
|
$514,629
$9.55 P/Share
|
|
Mar 02
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
57,060
-0.75%
|
$627,660
$11.54 P/Share
|
|
Mar 01
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
57,940
-0.38%
|
$637,340
$11.89 P/Share
|
|
Feb 23
2021
|
Eric Ostertag Director |
BUY
Exercise of conversion of derivative security
|
Direct |
111,395
+17.02%
|
$111,395
$1.17 P/Share
|
|
Feb 16
2021
|
Eric Ostertag Director |
SELL
Open market or private sale
|
Indirect |
133,149
-39.88%
|
$1,331,490
$10.0 P/Share
|